Skip to content

Clinical trials

Digestive System Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Digestive System Diseases Country / region: United States Clear all

187 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20051
20075
20083
200913
20107
201110
20126
201310
201410
20155
201610
201714
201812
20196
202012
202114
20229
202313
202410
20256
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed106
Terminated25
Recruiting21
Active, not recruiting19
Unknown status7
Withdrawn4
Enrolling by invitation3
Suspended1
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Exact Sciences Corporation6
Gilead Sciences6
M.D. Anderson Cancer Center5
Mirum Pharmaceuticals, Inc.5
Mayo Clinic4
Novartis Pharmaceuticals4
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins4
89bio, Inc.3
Bausch Health Americas, Inc.3
Boston Scientific Corporation3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Digestive System Diseases187
Gastrointestinal Diseases75
Intestinal Diseases46
Neoplasms41
Liver Diseases36
Digestive System Neoplasms35
Colonic Diseases31
Neoplasms by Site30
Gastrointestinal Neoplasms27
Colorectal Neoplasms23

Trials

Showing 1 to 25 of 187. Each trial links to its page on Pharma Observatory.

87 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.